Epilepsy Medications Drive Adverse Pregnancy Outcomes
TOPLINE:
Maternal epilepsy was associated with increased odds of adverse perinatal outcomes, but most associations were driven by prenatal exposure to antiseizure medications (ASMs) rather than epilepsy itself.
METHODOLOGY:
Researchers conducted a retrospective population-based cohort study using national health data from Scotland between 2009 and 2021.
This study included 629,200 pregnancies (2022 in women with epilepsy and 627,178 in women without epilepsy).
International Classification of Diseases, Tenth Revision codes were used to identify maternal epilepsy from pregnancy records or hospital admissions within 2 years prior to the estimated conception through pregnancy.
The analysis included exposure to ASMs, defined as any ASM dispensed between 30 days before the estimated conception and the end of pregnancy, with 4406 pregnancies exposed to ASMs and 624,794 unexposed.
The primary outcome was the association between maternal epilepsy and adverse perinatal outcomes; secondary outcomes included effect estimates for exposure to specific ASM monotherapies (valproate, carbamazepine, lamotrigine, levetiracetam, or topiramate) vs no exposure.
TAKEAWAY:
Compared with women without epilepsy, those with epilepsy showed increased odds of induced labour (adjusted odds ratio [aOR], 1.17; 95% CI, 1.02-1.34), after adjusting for prenatal exposure to ASMs.
Prenatal exposure to ASMs was associated with increased odds of preterm birth (aOR, 1.47; 95% CI, 1.25-1.74), induced labour (aOR, 1.38; 95% CI, 1.25-1.52), and NICU admission (aOR, 1.54; 95% CI, 1.33-1.78).
Valproate monotherapy showed the strongest association with congenital conditions (aOR, 3.91; 95% CI, 2.36-6.49), followed by carbamazepine monotherapy (aOR, 1.90; 95% CI, 1.16-3.10).
IN PRACTICE:
"Maternal epilepsy is associated with many adverse perinatal outcomes, but most are driven by prenatal ASM exposure. We postulate that joint comprehensive care between obstetricians and epileptologists or other specialists who prescribe ASMs could improve perinatal outcomes," the authors of the study wrote.
SOURCE:
This study was led by Paolo Pieirino Mazzone, Muir Maxwell Epilepsy Centre, University of Edinburgh, Edinburgh, Scotland, and was published online on June 16, 2025, in Epilepsia.
LIMITATIONS:
This study was limited by its inability to account for epilepsy characteristics such as aetiology, type/syndrome, or seizure frequency/severity. This study could not determine whether individuals in the group of women with epilepsy without prenatal exposure to ASMs were misclassified because some might have had resolved epilepsy or never had epilepsy. ASM treatment duration, trimester of dispensation, and reasons for ASM use aside from epilepsy were not investigated.
DISCLOSURES:
This study did not receive any external funding. One author reported receiving consultant, lecture, and/or conference-attendance fees from various sources, and another author reported receiving external fund support unrelated to this study.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
Cyberattack on UK Health Firm Contributed to Patient Death
A cyberattack that caused disruption at hospitals in London last year contributed to the death of a patient, health officials have confirmed for the first time. The incident occurred after a Russian hacking gang in June 2024 targeted Synnovis, a contractor that provides blood testing, transfusion and other pathology services to the UK's National Health Service, or NHS. The breach triggered a major crisis at health-care providers predominantly in the southeast of the city.
Gizmodo
2 hours ago
- Gizmodo
Good News! Caffeine Might Help Your Cells Live Longer
As if we needed any other reason to drink coffee or tea, new research provides insight into how caffeine supports health and longevity. Researchers in London studying fission yeast—a single-celled organism similar to human cells—have revealed that caffeine impacts aging via an ancient cellular energy system. Their study, published yesterday in the journal Microbial Cell, bolsters previous research suggesting that caffeine reduces the risk of age-related diseases and carries important implications for future longevity research. Plus, it gives you a good comeback next time your partner tells you you're drinking too much coffee. While most people think of caffeine within the context of coffee or tea, it is a naturally occurring central nervous system stimulant found in coffee beans, tea leaves, cocoa beans, kola nuts, and more. Perhaps unsurprisingly, caffeine is the most widely used psychoactive stimulant in the world. While the energy boost our cup of Joe delivers each morning is enough for most of us to justify its daily consumption, caffeine has also been associated with a number of health benefits, such as depression relief, longer lifespan, and a lower risk of cardiovascular disease and type 2 diabetes. The team had previously discovered that caffeine promotes lengthier cell lives by influencing TOR (Target of Rapamycin)—a biological switch that instructs cells when to grow given the availability of food and energy. More broadly, the growth regulator manages the energy and stress responses of living things. In the new study, however, the team found that caffeine actually impacts TOR indirectly by activating a system called AMPK, essentially a sort of cellular fuel gauge, as described by a Queen Mary University of London statement. 'When your cells are low on energy, AMPK kicks in to help them cope,' Charalampos Rallis, senior author of the study and a researcher at Queen Mary University of London's Research Centre of Molecular Cell Biology, said in the statement. 'And our results show that caffeine helps flip that switch.' Rallis and his colleagues used the yeast model to demonstrate that caffeine's influence on AMPK positively affects functions related to aging and disease, such as cell growth, DNA repair, and stress response. 'These findings help explain why caffeine might be beneficial for health and longevity,' said John-Patrick Alao, lead author of the study and a biochemist at the University of East London. 'And they open up exciting possibilities for future research into how we might trigger these effects more directly—with diet, lifestyle, or new medicines.' Coffee and tea lovers, rejoice!
Gizmodo
2 hours ago
- Gizmodo
Webb Telescope Just Did Something It's Never Done Before—and Astronomers Are Thrilled
Since it began its science operations in July 2022, the James Webb Space Telescope has been probing the atmospheres of alien planets to study their potential for habitability. For the first time, however, Webb has discovered its own exoplanet, finding a young system hidden in a swirling cloud of dust and debris. Webb has captured a previously unseen exoplanet, the lightest planet imaged so far—an accomplishment made possible by the space-based telescope's advanced capabilities. The recent discovery, detailed in a paper published Wednesday in the journal Nature, marks Webb's first discovery of an exoplanet and opens up a new window into hidden, Saturn-like worlds. 'The planets are much fainter by orders of magnitudes than their parent stars, and seen from Earth or from JWST, they are angularly very close to them,' Anne-Marie Lagrange, research director at the French National Center for Scientific Research and lead author of the paper, told Gizmodo. 'Hence, when looking at a planet we see only the star.' In order to overcome this issue, the team behind the new discovery used a coronagraph—a telescopic attachment for Webb's Mid-Infrared Instrument. The coronagraph recreates the effect of a solar eclipse, blocking the light from a star to make its surroundings more visible. Using the coronagraph, the scientists spotted a young planetary system that's only a few million years old. The system, named TWA 7, has three distinct rings, one of which is especially narrow while being surrounded by two areas that hold almost no matter. In Webb's image, something lies within the heart of the narrow ring, which the scientists behind the study concluded is an exoplanet. The newly discovered exoplanet, dubbed TWA 7b, is more massive than Neptune but around 30% less massive than Jupiter, the largest planet of our solar system. TWA 7b, designated a sub-Jupiter, has a mass similar to that of Saturn's and orbits around a star that formed approximately 6.4 million years ago. The planet maintains a large distance of 52 astronomical units (in which 1 au is the average distance between the Earth and the Sun) from its star. 'It is also the first planet explaining gaps in a disk,' Lagrange said. 'It is unique to explain disk-planet interactions during the early phases of planetary systems.' Planets form from the material leftover from the birth of a star, which create a swirling disk of matter. Previous observations of these protoplanetary disks has revealed ring-like structures and gaps, which were believed to be signatures of unseen planets. So far, there were no direct observations of those planets. The mass and orbital features of TWA 7b, however, match the predicted properties of an exoplanet that may have formed in the gap between the first and second ring of the disk. By using Webb to observe young, faint planets, scientists have unlocked a new doorway into the discovery of alien worlds. 'In terms of imaging, it opens the possibility to image Saturn-like planets. In further steps, it will allow us to characterize the atmosphere of Saturn-like, non irradiated planets,' Lagrange said. 'It is a big step. It helps us knowing what is complicated when searching for very light planets.'
